Nutrafol’s latest product ushers the brand into new (hair care) territory. And it’s a terrific option for guys with short ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...

US stock futures (ES=F, NQ=F, YM=F) are approaching record highs from earlier in the week, but there are concerns about ...

Delhi's new BJP-led administration announced a significant healthcare reform strategy, addressing staffing shortages, ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Hims & Hers bought an at-home lab test­ing com­pa­ny as it branch­es out in­to oth­er clin­i­cal ar­eas be­yond its re­cent ...

Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to ...

The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

Stock futures rise as traders eye Fed minutes and tariffs. Tesla, Intel, and Buffett-backed Constellation lead pre-market ...